Prentice Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Prentice Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,007	Closed	-$227K	–	111
2024 Q4	$227K	Buy	4,007 +22	+0.6%	+$1.23K	0.07%	103
2024 Q3	$206K	Sell	3,985 -3,012	-43%	-$141K	0.06%	106
2024 Q2	$291K	Sell	6,997 -254	-4%	-$11.4K	0.09%	97
2024 Q1	$393K	Buy	7,251 +757	+12%	+$38.6K	0.14%	84
2023 Q4	$333K	Buy	6,494 +132	+2%	+$6.93K	0.13%	87
2023 Q3	$369K	Buy	6,362 +79	+1%	+$4.84K	0.17%	75
2023 Q2	$402K	Buy	6,283 +850	+16%	+$57K	0.18%	74
2023 Q1	$377K	Buy	5,433 +252	+5%	+$17.8K	0.18%	68
2022 Q4	$373K	Buy	5,181 +283	+6%	+$21.3K	0.19%	63
2022 Q3	$349K	Buy	+4,898	New	+$355K	0.19%	55
2022 Q2	–	Sell	-3,844	Closed	-$278K	–	148
2022 Q1	$278K	Buy	+3,844	New	+$258K	0.13%	75
2021 Q4	–	Sell	-3,520	Closed	-$208K	–	126
2021 Q3	$208K	Buy	3,520 +31	+0.9%	+$2.04K	0.1%	100
2021 Q2	$233K	Buy	3,489 +1,232	+55%	+$80.3K	0.12%	93
2021 Q1	$142K	Buy	+2,257	New	+$140K	0.08%	111

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prentice Wealth Management's BMY Position: Q1 2025 in Review

Prentice Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 4,007 shares — an estimated $227K sold.

Prentice Wealth Management first reported a position in BMY in Q1 2021 and held it in 14 quarters. The position peaked at $402K in Q2 2023. 2,486 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Prentice Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Prentice Wealth Management sold 4,007 Bristol-Myers Squibb shares in Q1 2025, an estimated $227K.
Prentice Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 14 quarters.
Prentice Wealth Management's Bristol-Myers Squibb position peaked at $402K in Q2 2023.
2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Prentice Wealth Management's 13F filing for Q1 2025, filed 17 Apr 2025.